Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9CNS 8Head & Neck 5Breast 5Thoracic 4Genitourinary 4Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Endocrine 1

Conditions

Pheochromocytoma 1

Interventions

Eating 5Standard of Care 4Radiofrequency Ablation 4Exercise 4Endoscopic Mucosal Resection 4Surgical Procedures, Operative 3Radiosurgery 3Adrenalectomy 3lutetium Lu 177 dotatate 2Yoga 2Saline Solution 2Robotic Surgical Procedures 2Resistance Training 2Proton Therapy 2Propofol 2Palliative Care 2Octreotide 2Magnetic Resonance Imaging 2Lutetium-177 2Liquid Biopsy 2Interviews as Topic 2Hydrocortisone 2Diet, Mediterranean 2Diet 2Desflurane 2Data Collection 2Conversion to Open Surgery 2Control Groups 2Calcium 23-Iodobenzylguanidine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Dexmedetomidine × Endocrine × Clear all
NCT06037135 2023-10-06

Dexmedetomidine Infusion During Laparoscopic Adrenalectomy

Yonsei University

Phase NA Completed
40 enrolled
Endocrine

Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡